SCHEMBL23349705

SCHEMBL23349705

c1ccc(-c2nc(-c3ccc4c(c3)sc3ccccc34)nc(-c3ccc4c(c3)sc3c(-c5cccc6c5oc5ccccc56)cccc34)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 11/20 0.42
PIK3CD O00329 3/20 0.42
PIK3CB P42338 3/20 0.42
ALOX5 P09917 3/20 0.40
BRD4 O60885 1/20 0.40
PIK3CA P42336 1/20 0.40
MTOR P42345 1/20 0.40
PIK3CG P48736 1/20 0.40
KCNH2 Q12809 1/20 0.40
BRDT Q58F21 1/20 0.40
PARP14 Q460N5 1/20 0.34
MAPT P10636 2/20 0.34
GGPS1 O95749 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
PTGES2 Q9H7Z7 1/20 0.34
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23349709 0.97 PRKDC (0.40) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349834 0.97 PRKDC (0.40) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349708 0.97 PRKDC (0.41) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL24216169 0.97 ALOX5 (0.43) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349759 0.96 ALOX5 (0.39) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349787 0.96 PRKDC (0.42) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349659 0.96 ALOX5 (0.40) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL26193099 0.96 ALOX5 (0.42) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349546 0.95 PRKDC (0.41) PRKDCPIK3CDPIK3CBALOX5BRD4
SCHEMBL23349684 0.95 ALOX5 (0.41) PRKDCPIK3CDPIK3CBALOX5BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807632-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-11-07 US disclosed
US-11807632-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-11-07 US disclosed
US-20210139469-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807632-B2 Heterocyclic compound and organic light emitting device comprising the same ARNT, AHR, DRD1 PRKDC 4586/4885PIK3CD 4713/4885PIK3CB 4790/4885
US-20210139469-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME ARNT, AHR, DRD1 PRKDC 4586/4885PIK3CD 4713/4885PIK3CB 4790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.